US 10583200
Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
granted A61KA61K2039/523A61K39/3955
Quick answer
US patent 10583200 (Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/523, A61K39/3955, A61K47/6901, A61K48/00